Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 12Sarcoma 7Meningioma 6Glioma 6Pancreatic Neoplasms 5Lung Neoplasms 5Esophageal Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Glioblastoma 4Carcinoma, Hepatocellular 4Solid Tumor, Adult 3Rhabdomyosarcoma 3Radiation Injuries 3Liver Neoplasms 3Head and Neck Neoplasms 3Chondrosarcoma 3Uterine Cervical Neoplasms 2Thymus Neoplasms 2Solid Tumor 2Prostate Adenocarcinoma 2Pituitary Neoplasms 2Pinealoma 2Osteosarcoma 2Oligodendroglioma 2Nerve Sheath Neoplasms 2Nasopharyngeal Carcinoma 2

Interventions

pembrolizumab 1Watchful Waiting 1Proton Therapy 1Imatinib Mesylate 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiopericytoma × Proton Therapy × Clear all
NCT01117844 2024-11-07

Proton Radiation For Meningiomas and Hemangiopericytomas

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
53 enrolled
CNS

Hemangiopericytoma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡